- recruiting
Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer
This study compares a quick, safe MRI scan to standard ultrasound for finding liver cancer early in people at high risk, like those with liver scarring (cirrhosis). The aim is to see if MRI can detect cancers that ultrasound might miss, offering a better screening method.
United Kingdom - recruiting
Prospective Cohort for Early Detection of Liver Cancer
This study aims to find better ways to detect liver cancer early in people with liver scarring (cirrhosis). Researchers will collect samples and information from 3000 volunteers to develop new, more effective tests.
United Kingdom - recruitingNA
Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients
This study looks at a new device called Alfapump for people with liver disease and severe fluid build-up (ascites). It compares the Alfapump to regular fluid drainage to see which is better and more cost-effective over one year.
France - not yet recruitingNA
4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis
This study uses a special MRI scan (4D-Flow MRI) to better understand liver problems in people with cirrhosis. It aims to find a simple, non-invasive way to check a condition called portal hypertension, which is currently measured with an invasive procedure.
France - recruiting
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
This study looks at a new blood test called mSEPT9 to predict liver cancer (HCC) in people with cirrhosis. We're hoping it can help doctors find liver cancer earlier and tailor treatment plans better for each person.
France - recruitingNA
PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)
This study aims to understand how the body's unconscious control system, called the Autonomic Nervous System (ANS), affects liver cancer (HCC). We hope to find new ways to detect HCC early and create more personalised treatments by measuring ANS activity in people with cirrhosis.
France